ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data

Author:

Yao Yuhua123,Lv Yaping14ORCID,Tong Ling5,Liang Yuebin46,Xi Shuxue46,Ji Binbin46ORCID,Zhang Guanglu1,Li Ling7,Tian Geng46,Tang Min8,Hu Xiyue9,Li Shijun5,Yang Jialiang456ORCID

Affiliation:

1. School of Mathematics and Statistics, Hainan Normal University , Haikou 570100, China

2. Key Laboratory of Data Science and Intelligence Education, Ministry of Education, Hainan Normal University , Haikou, China

3. Key Laboratory of Computational Science and Application of Hainan Province, Hainan Normal University , Haikou, China

4. Genies Beijing Co., Ltd. , Beijing 100102, China

5. Chifeng Municipal Hospital, Chifeng , Inner Mongolia 024000, China

6. Qingdao Geneis Institute of Big Data Mining and Precision Medicine , Qingdao 266000, China

7. Basic Courses Department, Zhejiang Shuren University , Hangzhou 310000, China

8. School of Life Sciences, Jiangsu University , Zhenjiang, 212013, China

9. Dept. of Colorectal Surgery, National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Science , 17 Panjiayuan Nanli, Chaoyang District, Beijing, China , 100021

Abstract

Abstract Breast cancer patients often have recurrence and metastasis after surgery. Predicting the risk of recurrence and metastasis for a breast cancer patient is essential for the development of precision treatment. In this study, we proposed a novel multi-modal deep learning prediction model by integrating hematoxylin & eosin (H&E)-stained histopathological images, clinical information and gene expression data. Specifically, we segmented tumor regions in H&E into image blocks (256 × 256 pixels) and encoded each image block into a 1D feature vector using a deep neural network. Then, the attention module scored each area of the H&E-stained images and combined image features with clinical and gene expression data to predict the risk of recurrence and metastasis for each patient. To test the model, we downloaded all 196 breast cancer samples from the Cancer Genome Atlas with clinical, gene expression and H&E information simultaneously available. The samples were then divided into the training and testing sets with a ratio of 7: 3, in which the distributions of the samples were kept between the two datasets by hierarchical sampling. The multi-modal model achieved an area-under-the-curve value of 0.75 on the testing set better than those based solely on H&E image, sequencing data and clinical data, respectively. This study might have clinical significance in identifying high-risk breast cancer patients, who may benefit from postoperative adjuvant treatment.

Funder

Natural Science Foundation of Inner Mongolia Autonomous Region of China

Natural Science Foundation of Hainan Province

Education Department of Hainan Province

Hainan Provincial Natural Science Foundation of China

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3